
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
Author(s) -
Ettore Capoluongo,
Benedetta Pellegrino,
Laura Arenare,
Daniela Califano,
Giovanni Scambia,
Luca Beltrame,
Violeta Serra,
Giulia Scaglione,
Anna Spina,
Sabrina Chiara Cecere,
Rossella De Cecio,
Nicola Normanno,
Nicoletta Colombo,
Domenica Lorusso,
Daniela Russo,
C. Nardelli,
Maurizio D’Incalci,
Alba LlopGuevara,
Carmela Pisano,
Gustavo Baldassarre,
Delia Mezzanzanica,
Grazia Artioli,
M. Setaro,
Giulia Tasca,
C. Roma,
Nicoletta Campanini,
Saverio Cinieri,
A. Sergi,
Antonino Musolino,
Francesco Perrone,
Paolo Chiodini,
Sergio Marchini,
Sandro Pignata
Publication year - 2022
Publication title -
esmo open
Language(s) - English
Resource type - Journals
ISSN - 2059-7029
DOI - 10.1016/j.esmoop.2022.100585
Subject(s) - olaparib , rad51 , homologous recombination , carboplatin , medicine , genome instability , ovarian cancer , oncology , genetic testing , cancer , chemotherapy , cancer research , bioinformatics , genetics , dna , biology , polymerase , poly adp ribose polymerase , dna damage , cisplatin